Metraipolis › archive › dc_da045930420d
Efficacy and safety of GLP-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized clinical trials — Europe PMC PMID:42105060
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42105060
- DOI
- 10.1007/s10072-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T13:20:50.246Z
- SHA-256 of the archived text
5b4575e82ac4ce601c3281ba4dd4e1dec7bb11b72b113debe48018a47ecf4a89- Stable URL of this page
https://metraipolis.com/documento/dc_da045930420d
How to cite
Efficacy and safety of GLP-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized clinical trials — Europe PMC PMID:42105060 — Europe PMC (en), https://europepmc.org/article/MED/42105060 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da045930420d (Metraipolis archive dc_da045930420d, sha256 5b4575e82ac4ce601c3281ba4dd4e1dec7bb11b72b113debe48018a47ecf4a89)
BibTeX
@misc{dcda045930420d,
title = {Efficacy and safety of GLP-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized clinical trials — Europe PMC PMID:42105060},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42105060},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da045930420d; sha256 5b4575e82ac4ce601c3281ba4dd4e1dec7bb11b72b113debe48018a47ecf4a89},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42105060. Agents can read the archived copy with the MCP tool read_document.